IndraLab

Statements



reach
"In contrast, within 5 days 400 mg of hydroxychloroquine daily lowered elevated levels of calcium and 1,25-(OH) 2D by 37% and 72%, respectively, in a hypercalcemic patient with sarcoidosis."

reach
"Hydroxychloroquine has been suspected to inhibit the conversion of 25 (OH) D to its biologically more active form 1,25-dihydroxyvitamin D, and as such, Ruiz-Irastorza et al reported that hydroxychloroquine was associated with higher 25 (OH) D levels."

reach
"Hydroxychloroquine prescribed in several autoimmune diseases may inhibit the conversion of 25 (OH) D to 1,25 (OH) 2 D."

reach
"Hydroxychloroquine also impairs 25 (OH) D3-1-alpha-hydroxylase, and therefore, it is often chosen to treat hypercalcemia."

reach
"Hydroxychloroquine is suspected to inhibit the conversion of 25 (OH) D to its more biologically active form 1,25 (OH) 2 D but has also been found to protect against vitamin D deficiency."

reach
"Huisman and al. found lower 1,25 (OH) 2D concentration in SLE patients treated with hydroxychloroquine and no significant difference in 25 (OH) D concentration among patients who use hydroxychloroquine and those who did not [XREF_BIBR]."

reach
"XREF_BIBR The antimalarial, HCQ, which is frequently used for the treatment of SLE, might impair vitamin D status in patients with lupus, since HCQ is supposed to inhibit the conversion of 25 (OH) D in 1,25 (OH) 2 by inhibiting the enzyme hydroxylase alpha1."

reach
"The antimalarial hydroxychloroquine (HCQ) is frequently used for the treatment of SLE and is supposed to inhibit the conversion of 25 (OH) D in 1,25 (OH) 2 D by inhibiting the enzyme hydroxylase alpha1."

reach
"Huisman et al. [XREF_BIBR] found lower 1,25 (OH) 2 D 3 levels in patients with lupus treated with HCQ, although circulating 25 (OH) D levels did not differ between treated and untreated patients."